latest news releases from the newsroom
Tekmira Provides Periodic Update on TKM-Ebola Program
VANCOUVER, British Columbia, Oct. 21, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, provides an update on its Ebola program. The Company is reporting it has commenced limited GMP manufacture of a new therapeutic specifically targeting the Ebola – Guinea variant, which is the viral variant responsible for the Ebola epidemic currently prevalent in West Africa. Supply of this new product will be available in early December, 2014, for potential use by various collaborators. As definitive agreements are established we will provide updates accordingly.
Proteon Therapeutics Inc.
Proteon Therapeutics Announces Pricing of Initial Public Offering
WALTHAM, Mass., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc., a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced the pricing of its initial public offering of 6,110,000 shares of its common stock at a public offering price of $10.00 per share, before underwriting discounts, commissions and estimated expenses. All of the shares of common stock are being offered by Proteon. The shares are scheduled to begin trading on the NASDAQ Global Market under the ticker symbol "PRTO" on October 22, 2014. In addition, Proteon has granted the underwriters a 30-day option to purchase up to 916,500 additional shares of common stock at the offering price. The offering is expected to close on October 27, 2014, subject to customary closing conditions.
Anchor BanCorp Wisconsin Inc.
Anchor BanCorp Wisconsin Inc. Announces Pricing of Initial Public Offering of Common Stock
MADISON, Wis., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Anchor BanCorp Wisconsin Inc. (the "Company"), the parent holding company of AnchorBank, fsb, today announced the pricing of its initial public offering of 371,959 shares of its common stock at a price to the public of $26.00 per share. The Company is offering 250,000 shares of common stock and selling stockholders are offering 121,959 shares of common stock. In addition, the Company has granted the underwriters an option to purchase up to an additional 55,794 shares of common stock from the Company to cover over-allotments. The shares are expected to begin trading on October 22, 2014 on the NASDAQ Global Select Market under the symbol "ABCW." The offering is expected to close on October 27, 2014, subject to the satisfaction of customary closing conditions.
Buckitdream Offers Giveaway To Branson's Necker Island
SEATTLE, Wash., Oct. 21, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Buckitdream.com – a social commerce site that helps people create, share, and achieve their bucket list dreams – is currently offering two people in the US the opportunity of a lifetime: a 4-night, 5-day exclusive dream experience from November 19 to 23 in the British Virgin Islands with Sir Richard Branson.
Sucampo Pharmaceuticals, Inc.
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
BETHESDA, Md., October 21, 2014 and OSAKA, Japan, October 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, and Takeda Pharmaceutical Company Limited (Takeda) today announced that on October 17, 2014, they entered into a global license, development, commercialization and supply agreement for AMITIZA
KYTHERA Biopharmaceuticals, Inc.
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
WESTLAKE VILLAGE, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on October 17, 2014, the Compensation Committee of the Company's Board of Directors granted three new employees options to purchase an aggregate of 28,500 shares of the Company's common stock. The exercise price of each option was $32.85, the closing trading price on the date of grant. The stock options were granted pursuant to the Company's 2014 Employment Commencement Incentive Plan, which was approved by the Company's Board of Directors in August 2014 under Rule 5653(c)(4) of The Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.
Lucara Diamond Corp
LUCARA’S EXCEPTIONAL STONE TENDERS BRING IN $136 MILLION IN 2014
October 21, 2014 (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond
Corp. (“Lucara” or the “Company”) is pleased to announce the results from its
third Exceptional Stone Tender of 2014. The sale of fourteen diamonds closed on
October 21, 2014 with all lots being sold for gross revenues of $46.4 million
($30,129 per carat). A total of 12 of the 14 stones sold for greater than $1.0
million, including 6 stones which sold for greater than $4.0 million each. The
highest value stones sold d
ShaMaran Petroleum Corp
SHAMARAN Q3 2014 FINANCIAL AND OPERATING RESULTS
October 21, 2014 - ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (TSX
VENTURE: SNM) (NASDAQ FIRST NORTH: SNM) is pleased to announce its financial
and operating results for the three and nine months ended September 30, 2014.
Unless otherwise stated all currency amounts indicated as “$” in this news
release are expressed in thousands of United States dollars.
-- The Company announced on October 15, 2014 that it will undertake a rights
offering to holders of c